hypogonadism; oral-t; aging men; health
-
New post-marketing clinical study for potential label expansion evaluating KYZATREX® (TU) CIII capsules in men ages 65–80 with hypogonadism
* The trial will also evaluate KYZATREX’s labeled titration protocol alongside a simplified once-daily dosing regimen, an important consideration for older adults who may benefit from more streamlined, easy-to-follow treatment plans...- madman
- Thread
- hypogonadism; oral-t; aging men; health
- Replies: 1
- Forum: Testosterone and Men's Health Articles
Sponsors
